baber/WOPTO huggingface dataset:
Patent NZ-551311-A (NZ)
Title: A hydraulic valve and a double acting hydraulic actuator
Inventor: GILLANDERS WILLIAM STEVEN
Filed: 2006-11-15
Abstract: A hydraulic valve (100) has a body (1) provided with an internal chamber (2). A first port (3) is provided at a first end of the chamber (2), a second port (5) at a second end of the chamber, and a third port (7) in a side of the chamber. A shuttle (9) is substantially sealingly engaged with the chamber (2) and has a first channel (10) extending from a first end to an opposite second end which provides a flow path between the first and second ports. The first channel (10) is provided with a one way valve (10b) which allows fluid flow from the first port (3) to the second port (5) but not in the opposite direction. The shuttle also contains a narrow bleed channel (10c) and is biased towards the second port. The shuttle (9) is slideable between a first position wherein it substantially closes the third port (7) and a second position wherein the third port (7) is open. When used as disclosed in conjunction with a double acting hydraulic actuator or cylinder, the actuator becomes self-regenerating and extension of the piston shaft becomes very rapid.
Patent NZ-553196-A (NZ)
Title: Bacteriophage and prophage proteins in cancer gene therapy
Inventor: BLASI UDO
IPC: A61K38/16
Filed: 2005-07-20
Abstract: Disclosed is the use of an isolated bacteriophage-derived protein for the manufacture of a medicament for the treatment of a proliferative disease or disorder, wherein the bacteriophage- derived protein induces a cell growth inhibitory activity or cell killing effect in eukaryotic cells.
Patent NZ-554117-A (NZ)
Title: Chair for chair lift
Inventor: SWITZENY KURT
Filed: 2007-03-22
Abstract: A chair of a chair lift having at least one seat with a seat cushion, which has a seat surface, and with a backrest, the seat surface having a rear edge adjacent to the backrest and a front edge located opposite the rear edge. The seat surface has a higher level of slip resistance in the region of the front edge than in the region of the rear edge. Alternatively, the seat surface has a higher level of slip resistance in the region of the front edge than in the backrest.
Patent NZ-554176-A (NZ)
Title: Medium-chain length fatty alcohols as stimulators of hematopoiesis
Inventor: PENNY CHRISTOPHER
IPC: A61K31/045
Filed: 2005-09-29
Abstract: Disclosed is the use of a composition comprising one or more compounds in the manufacture of a medicament for treating a disease requiring the stimulation of hematopoiesis in a patient in need of treatment, wherein said one or more medium-chain length fatty alcohols of formula 1: H3C(CH2)nOH, wherein n = 7-11. Particularly suitable compounds of formula 1 include decanol and dodecanol. These compounds are particularly suitable for treating diseases such as myelosuppression arising from chemotherapy or radiotherapy, neutropenia arising from chemotherapy or radiotherapy and anemia arising from chemotherapy or radiotherapy where stimulating hematopoiesis is required. These compounds are also suitable for treating a disease requiring increasing the number of red and/or white blood cells in a patient in need of treatment.
Patent NZ-555809-A (NZ)
Title: Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders
Inventor: GHARAT LAXMIKANT ATMARAM
IPC: A61K31/38
Filed: 2005-12-15
Abstract: Disclosed is a compound of formula (1), or a tautomer, stereoisomer, pharmaceutically acceptable salt, polymorph, or N-oxide thereof, wherein T, U, V, and W are each independently C, C=O, N, NRa, O, or S, such that at least one of T, U, V, and W are N, NRa, O, or S, and wherein the substituents are as defined in the specification. Also disclosed is the use of the compound for treating conditions characterized by or associated with an undesirable inflammatory immune response induced by or associated with an excessive secretion of TNF-alpha and PDE-4, such as asthma, bronchial asthma chronic obstructive pulmonary disease, allergic rhinitis, eosinophilic granuloma, nephritis, rheumatoid arthritis, cystic fibrosis, chronic bronchitis, multiple sclerosis, Crohn's disease, psoraisis, uticaria, adult vernal cojunctivitis, respiratory distress syndrome, rhematoid spondylitis, osteoarthritis, gouty arthritis, utelitis, allergic conjunctivitis, inflammatory bowel conditions, ulcerative coalitis, eczema, atopic dermatitis or chronic inflammation. Also disclosed is the use of the compound for treating a disease of the central nervous system, such as depression, amnesia, dementia, Alzheimer's disease, cardiac failure, or shock or cerebrovascular disease. Also disclosed is the use of the compound for treating insulin resistant diabetes.
Patent NZ-563711-A (NZ)
Title: Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met
Inventor: DINSMORE CHRISTOPHER J
IPC: A61K31/435
Filed: 2006-06-22
Abstract: Disclosed is a compound of formula (I) where R1 is optionally substituted aryl; optionally substituted heterocycle or NR10R11 and the rest of the variables are as is described in the disclosure. The compounds can be used for inhibiting tyrosine kinase MET and preventing or modulating metastasis of cancer. Also disclosed is a pharmaceutical composition containing a compound of formula (I) and the use of the compound to make a medicament useful for treating or preventing cancer. In particular the cancer is chosen from cancers of the brain, genitourinary tract, lymphatic system, stomach, larynx and lung head and neck squamous cell carcinoma, histiocytic lymphoma, lung adenocarcinoma, small cell lung cancer, non-small cell lung cancer, pancreatic cancer, papillary renal carcinoma, liver cancer, gastric cancer, colon cancer, multiple myeloma, glioblastoma and breast carcinoma.
Patent NZ-564181-A (NZ)
Title: Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain
Inventor: CID-NUNEZ JOSE MARIA
IPC: C07D405/12
Filed: 2006-06-16
Abstract: Disclosed are substituted tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain with binding affinities towards dopamine receptors, in particular dopamine D2 receptors, towards serotonin receptors, in particular 5-HT2A and 5-HT2C receptors, and pharmaceutical compositions comprising these compounds, the use thereof as a medicine, in particular for the prevention and/or treatment of a range of psychiatric and neurological disorders, in particular certain psychotic, cardiovascular and gastrokinetic disorders and processes for their production. These compounds are represented by general formula (I) and comprise also a pharmaceutically acceptable acid or base addition salt thereof, an N-oxide form thereof or a quaternary ammonium salt thereof, wherein all substituents are defined as in the specification.
Patent NZ-564890-A (NZ)
Title: Breathing mask device and method and mold for producing same
Inventor: BURZ JOHANN S
IPC: A61M16/06
Filed: 2006-07-19
Abstract: A breathing mask device 2 for administering a breathable gas, comprises a lip sealer 2 that in use is sealed against a contact surface of a user's face, a body 1 that in combination with the lip sealer defines part of a breathing mask interior I, a gel structure 3 that partially and/or intermittently transmits the retention forces acting on the body 1 to the user's face, and a gel material 4 defining the gel structure 3 which is received in a gel receiving chamber GA defined in part by an elastically deformable receiving wall 5 integrally formed onto a wall portion of the breathing mask device.
Patent NZ-582965-A (NZ)
Title: Compositions containing a synergic mixture of polyols and xyloglucanes as phytosanitary and bio-fertilising products
Inventor: SALVADOR PASCAL
IPC: A01N31/02
Filed: 2008-07-09
Abstract: Provided is an eliciting composition which comprises a synergistic mixture comprising XFGol combined with sorbitol, wherein XFGol is of formula depicted below. The composition can be used for adapting plants to abiotic stress or water stress.
Patent NZ-583939-A (NZ)
Title: Diagnostic method and kit for the detection of Mycobacterium and treatment of tuberculosis
Inventor: OLWILL SHANE A
IPC: A61K39/04
Filed: 2008-08-18
Abstract: Disclosed is a method for the detection of the presence of Mycobacterium, for example Mycobacterium bovis, in a biological sample, said method comprising the steps: providing a biological sample from an animal; and determining in vitro the presence or absence of, or the presence or absence of an immune response to, each member of the group of antigens comprising: an Rv3616 antigen, an MPB70 antigen, an MPB83 antigen, and an ESAT 6 antigen; wherein the identification of the presence of two or more of said antigens or of an immune response thereto is indicative of the presence of Mycobacterium in the biological sample. Further disclosed is a method of diagnosis of tuberculosis in a mammal, for example a reservoir mammal, the method comprising the steps: providing a biological sample from said animal; and determining in vitro the presence or absence of, or the presence or absence of an immune response to, each member of the group of antigens comprising an Rv3616 antigen, an MPB70 antigen, and an MPB83 antigen, wherein the identification of the presence of one or more of said antigens of said group of antigens, or of an immune response thereto, is indicative of the presence of tuberculosis infection in the mammal.
Patent NZ-586802-A (NZ)
Title: Imidazo[1,5-a]pyridine and imidazo[1,5-a]pyrazine derivatives for the treatment of inflammatory diseases
Inventor: PRICE STEPHEN
IPC: C07D487/04
Filed: 2008-12-18
Abstract: Disclosed are imidazo[1,5-a]pyridine and imidazo[1,5-a]pyrazine derivatives as represented by the general formula (I), wherein Z1 is CR1; R1 and R1' are independently H, alkyl, halo, CF3, CHF2, CN, ORA or NRARA; RA is independently H or alkyl; Z2 is CR2; Z3 is CR3 or N; R4 is H, alkyl or carbocyclyl; X4 is an optionally substituted phenyl ring; and wherein the remaining substituents are as defined herein. Also disclosed is a pharmaceutical composition which comprises a compound as defined above and optionally an additional chemotherapeutic agent for use in the inhibition of abnormal cell growth or in the treatment of a hyperproliferative disorder in a mammal; and particularly for the treatment of cancers and inflammatory diseases. Representative compounds of formula (I) include 5-(2-fluoro-4-iodophenylamino)-imidazo[1,5-a]pyridine-6-carboxylic acid (2-hydroxyethoxy)-amide and (S)-5-(4-bromo-2-fluorophenylamino)-N-(2-hydroxypropoxy)-imidazo[1,5-a]pyrazine-6-carboxamide.
Patent NZ-588520-A (NZ)
Title: Container for holding and dispensing a pressurised beverage with a pressurizing device suspended from a closure welded on the neck of the container
Inventor: LANDMAN BERNARDUS CORNELIS JOHANNES
IPC: B65D23/12
Filed: 2009-04-08
Abstract: 588520 A beverage dispenser (1) is disclosed comprising a container (2) manufactured substantially from plastic. The container (2) is provided with a dispensing means (4) which extends through a closure (15). The closure (15) is fixed to the neck (6) by a welding technique. A pressure device (9) is provided for pressurizing a beverage such as beer in the container and dispensing the beverage via the dispensing means (4). The pressure device (9) in the container (2) is suspended from the closure (15) by a suspension bracket (13)
Patent NZ-589662-A (NZ)
Title: Current control device including a mems switch coupled between line and load sockets
Inventor: FUJITA LINCOLN MAMORU
IPC: H01H59/00
Filed: 2010-12-02
Abstract: Disclosed is a current control device (200). The current control device (200) includes at least one line socket (226) configured to couple to a first power system, at least one load socket (228) configured to couple to a second power system and at least one micro-electromechanical system (MEMS) switching device (235). The at least one MEMS switching device (235) is coupled between the at least one line socket (226) and the at least one load socket (228) and is configured to selectably couple the first power system to the second power system. The at least one MEMS switching device (235) includes a line transient voltage suppressor (230) that is coupled across the at least one MEMS switching device (235).
Patent NZ-590192-A (NZ)
Title: Panel assembly with stiffening structural members along the sides and through the body, for a cementitius composite tilt slab panel and components for use in same
Inventor: KRALIC JOHN FRANK
IPC: E04C2/38
Filed: 2009-06-12
Abstract: 590192 Disclosed is a panel assembly for a composite structure to improve the strength and simplify construction. The panel assembly comprises a deck of at least one metal deck sheetand a peripheral edge extending from the deck, the deck and the peripheral edge defining a cavity arranged to receive a settable material which is cast on the deck in forming the composite structure. At least part of the peripheral edge is formed of a separate side member which is movable relative to the deck to change the effective area of the deck on which the settable material is able to be cast. The side member incorporates a base portion and an edge portion that upstands from the base portion, the base portion is arranged to locate under a portion of the deck, the amount of underlap between the deck and the base portion may be varied to vary the size of the effective area of the deck. One or more stiffening sheet metal members are disposed between the deck and the side member.
Patent NZ-590560-A (NZ)
Title: Indolinone Inhibitors of cell cycle kinases
Inventor: TREU MATTHIAS
IPC: A61K31/506
Filed: 2009-07-28
Abstract: Disclosed herein are indolinone compounds of formula (1), wherein the variables are defined in the specification, and the use thereof in the treatment of cancer, infections, inflammations and autoimmune diseases. Exemplified compounds include: 2-oxo-3-[1-phenylamine-1-phenymeth-(Z)-ylidene]-5-(4-fluorophenyl)sulfonyl-6-(3-methylamino-1-propynyl)-methyl--2,3-dihydro-1H-indole; and 2-oxo-3-{ 1-phenyl-1-[4-(4-methylpiperazinyl)phenylamino] -meth-(Z)-ylidene} -2,3-dihydro-1H-indole-6-N-cyclopentylpropanynyl amide.
Patent NZ-591987-A (NZ)
Title: Liquid test strip and the method
Inventor: WU YI-JEN
IPC: G01N21/76
Filed: 2008-10-17
Abstract: Disclosed is a liquid test strip comprising a substrate having at least one channel thereon, the channel having a first region, a second region and a third region that are arranged successively, the first region being used for a fluid sample to be introduced there into. The liquid test strip is characterized by: a first antibody localized in the first region for recognizing an analyte in the fluid sample; a saccharide localized in the first or the second region; a peroxidase localized in the first or the second region; a second antibody immobilized in the second region for recognizing the analyte in the fluid sample, and the second antibody and the first antibody being configured to recognize different epitopes of the analyte in the fluid sample; and an optical substrate and a substrate reagent, both localized in the third region, wherein the substrate reagent comprises a saccharide oxidase. Upon introduction of the fluid sample containing the analyte into the channel, the first antibody, the saccharide, and the peroxidase flow along with the fluid sample, a part of the peroxidase binds with the first antibody, the analyte and the second antibody so as to be retained in the second region allowing the other part of the peroxidase to flow along with the fluid sample to the third region. The saccharide arrives at the third region and is catalysed by the saccharide oxidase so as to produce hydrogen peroxide. The optical substrate is catalysed by the peroxidase arriving at the third region so as to react with the hydrogen peroxide to generate an optical signal. Also disclosed is a method of detecting the analyte using the liquid test strip.
Patent NZ-592212-A (NZ)
Title: Sporulation-deficient thermophilic microorganisms for the production of ethanol
Inventor: ATKINSON ANTHONY
IPC: C12R1/01
Filed: 2009-11-05
Abstract: Provided is a thermophilic microorganism comprising a modification that decreases sporulation compared with wild-type, wherein the modification inactivates the native spoOA gene. The microbe can be Geobacillus sp. The microbe can be further modified to increase its ethanol production by inactivation of lactate dehydrogenase gene.
Patent NZ-595227-A (NZ)
Title: Tricyclic indole derivates as pbr ligands
Inventor: O SHEA DENNIS
IPC: A61K51/04
Filed: 2010-03-26
Abstract: 595227 An indole-based in vivo imaging agent is provided by the present invention that binds with high affinity to PBR, has good uptake into the brain following administration, and which has good selective binding to PBR. The invention also includes a precursor compound useful in the synthesis of the in vivo imaging agent of the invention, as well as a method for synthesis of said in vivo imaging agent comprising use of said precursor compound, and a kit for carrying out said method. Also provided is a cassette for automated synthesis of the in vivo imaging agent. Further aspects of the invention include a radiopharmaceutical composition comprising the in vivo imaging agent of the invention, and methods for the use of said in vivo imaging agent. Compounds of the invention include: (+-)-11-(2-[18F]fluoroethyl)-8-methoxy-6,11-dihydro-5-thia-11-aza-benzo[a] fluorene-6-carboxylic acid diethyl amide, 9-(2-Fluoro-ethyl)-2-methyl-2,3,4,9-tetrahydro-1H-carbazole-4-carboxylic acid diethylamide and Methanesulfonic acid 2-(4-diethylcarbamoyl-2-methyl-1,2,3,4-tetrahydro-carbazol-9-yl)-ethyl ester.
Patent NZ-595514-A (NZ)
Title: Disposable diaper
Inventor: KUWANO SEIICHI
IPC: A61F13/15
Filed: 2010-02-19
Abstract: A disposable diaper wherein the gap occurring between the wearer’s skin and leakage preventive cuffs formed on both sides of a crotch region is reduced. A disposable diaper has a pair of cuffs (32, 33) extending in the front-rear direction (A) on both sides, respectively, of a crotch region and capable of stretching and contracting. One (32) of the pair of cuffs includes first elastic members (47) on the outer peripheral edge thereof. The other (33) of the pair includes a base edge section (44) fixed to the inner surface of said cuff (32), and also includes second elastic members (49) attached to a free edge section thereof. A third elastic member (60) is attached to at least either of the pair of cuffs (32, 33) so as to be adjacent to the portion to which the base edge section (44) is fixed.
Patent NZ-595980-A (NZ)
Title: A method and system for controlling a device
Inventor: NGUYEN HUNG TAN
IPC: G06F3/01
Filed: 2010-04-20
Abstract: Disclosed is a method for controlling a device. The method includes receiving, at a processing system (200), a first signal associated with a thought pattern of a user (220), the first signal is received from a single electroencephalogram (EEG) channel having sensed any one or a combination of a visual cortex, a parietal cortex, or the area in between the visual cortex and the parietal cortex. The processing system (200) then receives a second signal that is associated with a mental or emotional state of the user (220). The processing system (200) determines a thought pattern classification for the first signal by analysing and classifying the first signal and then generates one or more control signals based on at least one of the determined thought pattern classification of the first signal and the second signal. The one or more control signals control the operation of the device and activating a safety feature of the device based on the mental or emotional state.
Patent NZ-598981-A (NZ)
Title: Vegetable flavour
Inventor: KORTES JAN GERRIT
IPC: A23L27/23
Filed: 2010-10-07
Abstract: Patent No. 598981 Disclosed is a process to produce a vegetable flavour comprising a) preparing a composition comprising a vegetable, an oil and a yeast extract and/or yeast autolysate, b) intimately mixing the composition in an extruder at a temperature between 100ºC and 160ºC and a reaction time between 1 second and 1 week, sufficient for the concentrated vegetable flavour to develop.
Patent NZ-600456-A (NZ)
Title: Vaccination syringe
Inventor: THORLEY CRAIG STEPHEN
IPC: A61M5/32
Filed: 2010-11-11
Abstract: Disclosed is a replaceable needle assembly (30) for a retractable, prefilled syringe (10). The disclosure notes that the practice of sharing needles without adequate sterilisation is a major contributor to the transfer of HIV. Syringes have been developed to include a retraction mechanism to prevent re-use and/or needle stick injury. The replaceable needle assembly (30) for a retractable syringe comprising a barrel (11) having a mounting member (16) and a plunger (20), whereby the retractable needle assembly (30) can be replaced by a user without affecting the retraction mechanism. The replaceable needle assembly (30) comprises a needle mount (36), retractable needle (39) and a needle retainer (35). The needle mount (36) is removably mountable to the mounting member (16) of the barrel (11). The retractable needle (39) is removably mounted to the needle mount (36) and is capable of being engaged by the plunger (20) to facilitate retraction of the retractable needle (39). The needle retainer (35) comprises a plurality of fingers that releasably engage the retractable needle (39) to prevent inadvertent retraction of the retractable needle (39) until the plunger (20) engages the retractable needle (39) for retraction.
Patent NZ-600676-A (NZ)
Title: Method and arrangement for reporting channel state information in a telecommunication system
Inventor: PARKVALL STEFAN
IPC: H04W88/08
Filed: 2011-03-31
Abstract: A method and an arrangement (800) in a user equipment (420) for reporting Channel State Information, CSI, and a method and an arrangement (1000) in a base station (410) for obtaining CSI are provided. The user equipment (420) is in connection with the base station (410) in a cellular communication network (400). After receiving a receiving (702) a grant in a subframe n to be used for CSI reporting, from the base station, the user equipment determines (703) subframe type of a subframe n+p. The user equipment then reports (704) to the base station, CSI reflecting channel conditions in subframes of the type corresponding to the subframe type of subframe n+p.
Patent NZ-608086-A (NZ)
Title: Cooking container and cooking method
Inventor: GOLD HOWARD MARC
IPC: A47J29/02
Filed: 2011-08-30
Abstract: Disclosed is a container (2) adapted to house a cooking egg (10) during cooking, wherein said is a pouch which is water permeable, and is impermeable to liquids of the viscosity of raw albumen and raw vitellus, and has an in use top region (12) and an in use bottom region (14), and said top comprises an aperture so sized as to allow the introduction of a raw egg into the container. The invention also comprises a method of cooking an initially raw or only partly precooked foodstuff, comprising the steps of placing the foodstuff in a container which is water permeable and is impermeable to liquids of the viscosity of raw albumen and raw vitellus, and has an in use top region and an in use bottom region, and said top comprises an aperture so sized to allow the introduction of a raw or precooked foodstuff into the container, placing the container in sufficiently heated water, leaving the container in the heated water for a user defined period of time, removing the container from the water; and inverting the container to eject the cooked foodstuff.
Patent NZ-610509-A (NZ)
Title: Turbine system and method
Inventor: CHRISTOPHER THEODORE J
IPC: F03B17/06
Filed: 2011-11-01
Abstract: 610509 Some embodiments of a turbine system described herein provide a turbine that rotates in response to off-axis fluid flow, such as water flowing in a generally horizontal direction that is generally perpendicular to a vertical axis of rotation. The rotation of the turbine can drive a generator to output electrical energy. The turbine has a central portion that is convex in the upwardly facing direction to resemble a bell curve, and there are upwardly projecting fins.